JANSSEN DARATUMUMAB daratumumab 400 mg/20 mL concentrated solution for infusion vial Cancelled under Section 30(1)(c) of the Act
Product name
JANSSEN DARATUMUMAB daratumumab 400 mg/20 mL concentrated solution for infusion vial
Sponsor
ARTG
281845
Date of effect
Decision type
Cancelled under Section 30(1)(c) of the Act